These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 86416

  • 1. [Plasma level and effectiveness of propafenone and its organ distribution (author's transl)].
    Blanke H, Aschbrenner B, Karsch KR, Kreuzer H.
    Dtsch Med Wochenschr; 1979 Apr 20; 104(16):587-91. PubMed ID: 86416
    [No Abstract] [Full Text] [Related]

  • 2. [Effectiveness of propafenon and disopyramide in ventricular extrasystole. Comparative study].
    Kenedi P.
    MMW Munch Med Wochenschr; 1982 Aug 27; 124(34):734-6. PubMed ID: 6182460
    [No Abstract] [Full Text] [Related]

  • 3. Clinical studies with propafenone--a new antiarrhythmic agent.
    Prabhakaran SN, Bhatia ML.
    Indian Heart J; 1984 Aug 27; 36(2):107-10. PubMed ID: 6202621
    [No Abstract] [Full Text] [Related]

  • 4. [Significance of cardiac arrhythmias in the aged and their treatment with propafenone controlled by plasma level].
    Lachnit KS, Rieder L.
    Z Gerontol; 1985 Aug 27; 18(6):343-52. PubMed ID: 2420079
    [Abstract] [Full Text] [Related]

  • 5. [Serum concentration and AV-conduction time in oral treatment with propafenone during a several-days period (author's transl)].
    Meyer-Estorf G, Keller K, Beck OA, Hochrein H.
    Z Kardiol; 1980 Jun 27; 69(6):417-20. PubMed ID: 6160684
    [Abstract] [Full Text] [Related]

  • 6. [Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG].
    Ferrara E, Vitali A, Cucchi GF.
    Minerva Cardioangiol; 1985 Sep 27; 33(9):553-6. PubMed ID: 2418385
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Indications and risks of anti-arrhythmia treatment with propafenone (author's transl)].
    Beck OA, Hochrein H.
    Dtsch Med Wochenschr; 1978 Aug 11; 103(32):1261-5. PubMed ID: 78793
    [Abstract] [Full Text] [Related]

  • 10. [Clinical pharmacology of propafenone].
    Ambrosioni E, Marchesini B.
    G Ital Cardiol; 1984 Apr 11; 14(4):285-92. PubMed ID: 6735021
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical experiences with a new anti-arrhythmia agent propafenon].
    Seipel L, Fischer G, Wiebringhaus E.
    Verh Dtsch Ges Inn Med; 1976 Apr 11; 82 Pt 2():1229-31. PubMed ID: 70898
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Propafenon, a new antiarrhythmic agent for the treatment of ectopic and rapid cardiac arrhythmias (author's transl)].
    Beck OA.
    Med Klin; 1975 Jan 17; 70(3-2):95-101. PubMed ID: 48183
    [Abstract] [Full Text] [Related]

  • 17. [Propafenon and propranolol in the management of cardiac extrasystoles (author's transl)].
    Beck OA, Ihle C, Hochrein H.
    Dtsch Med Wochenschr; 1982 Apr 16; 107(15):579-83. PubMed ID: 6175494
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Antiarrhythmic drugs in chronic ventricular extrasystole (author's transl)].
    Klein G, Wirtzfeld A, Schlegel J, Himmler C, Neiss A.
    Dtsch Med Wochenschr; 1980 Feb 08; 105(6):189-94. PubMed ID: 6153310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.